Enrasentan
Enrasentan (SB 217242) is an endothelin (ET) receptor antagonist. Enrasentan has antihypertensive effects[1].
Product Specifications
CAS Number
[167256-08-8]
Product Name Alternative
SB 217242
UNSPSC
12352005
Target
Endothelin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/enrasentan.html
Purity
98.39
Smiles
O=C(O)[C@@H]1[C@H](C2=C([C@H]1C3=CC=C(C=C3OCCO)OC)C=C(C=C2)OCCC)C4=CC5=C(C=C4)OCO5
Molecular Formula
C29H30O8
Molecular Weight
506.54
References & Citations
[1]Alessandro Cosenzi, et al. Antihypertensive treatment with enrasentan (SB217242) in an animal model of hypertension and hyperinsulinemia. J Cardiovasc Pharmacol. 2002 Apr;39 (4) :488-95.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15123208 1 Vial
Lentiviral mouse Borcs7 shRNA (UAS) - Lentiviral mouse Borcs7 shRNA (UAS, iRFP) plasmid
Ask
View Details 